AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

CSL LIMITED

172.250

+0.6800.40%

Volume:603.47K

Turnover:104.47M

Market Cap:82.49B

PE:-23.08

High:175.365

Open:172.800

Low:171.000

Close:171.570

52wk High:219.589

52wk Low:90.000

Shares:478.91M

Float Shares:478.91M

Volume Ratio:0.77

T/O Rate:0.13%

Dividend:4.12

Dividend Rate:2.39%

EPS(TTM):-7.463

EPS(LYR):-7.463

ROE:-15.83%

ROA:7.26%

PB:4.00

PE(LYR):-23.08

Loading ...

Overview Company News Filings

CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY

THOMSON REUTERS

3 ASX Dividend Stocks Paying Investors While They Wait

Simply Wall St.

Accenture Stock And 2 More Dividend Shares Yielding Over 3%

Simply Wall St.

3 Australian Dividend Powerhouses Offering 3% Yields In An Uncertain Rate Outlook

Simply Wall St.

3 Dividend Stocks For Reliable Income When Cash Rates Feel Less Rewarding

Simply Wall St.

Top ASX Dividend Stocks For August 2026

Simply Wall St.

Global Drugmakers Invest Billions to Boost US Presence

Australian Dividend Stocks With 3% Yields That Deserve A Closer Look

Simply Wall St.

Global Drugmakers Invest Billions to Boost US Presence

ASX Dividend Stocks With 5% Yields That Stand Out Right Now

Simply Wall St.

ASX Midday Sector Update: Healthcare Stocks Advance, Financial Sector Struggles

MT Newswires Live

Carlisle Companies (CSL) Could Be 6% Undervalued After Guidance Raise And Buyback Boost

Simply Wall St.

3 Dividend Powerhouses for More Reliable Income in Volatile Markets

Simply Wall St.

3 Australian Dividend Stocks Paying Over 5% That Income Investors May Want To Check

Simply Wall St.

Pediatric ANDEMBRY Phase 3b Success Might Change The Case For Investing In CSL (ASX:CSL)

Simply Wall St.

CSL Says European Commission Revokes Marketing Authorization for Tavneos

MT Newswires Live

Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End

EU Revokes Marketing Authorisation for CSL-Partnered Tavneos in EU, EEA

CSL Ltd - European Commission Adopts Decision to Revoke Marketing Authorisation for Tavneos in the European Union and European Economic Area Countries

THOMSON REUTERS

CSL Ltd - Tavneos Will no Longer be Available for Prescribing in the EU and Eea

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/CSL.AU/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CSL.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","market":"AU","secType":"STK","nameCN":"CSL LIMITED","latestPrice":172.25,"timestamp":1788235038381,"preClose":171.57,"halted":0,"volume":603472,"delay":0,"changeRate":0.003963396864253697,"nameEN":"CSL LIMITED","floatShares":478911979,"shares":478911979,"eps":-7.461063013209568,"marketStatus":"Trading","change":0.68,"latestTime":"09-01 13:57:21 AEST","open":172.8,"high":175.365,"low":171,"amount":104466675,"amplitude":0.025442,"askPrice":172.29,"askSize":305,"bidPrice":172.25,"bidSize":218,"shortable":3,"etf":0,"ttmEps":-7.461063013209568,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1788242400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":171.57,"dividendRate":0.023905,"openAndCloseTimeList":[[1788220800000,1788242400000]],"volumeRatio":0.769362,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"CSL.AU","preClose":171.57,"auctionPrice":172.8,"auctionVolume":33711,"auctionTime":1788220751834,"referenceTime":1788172203092,"auction":1,"marketStatus":"盘前竞价","timestamp":1788220751834}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"CSL.AU\",,,,,undefined,":{"symbol":"CSL.AU","floatShares":478911979,"roa":"7.26%","roe":"-15.83%","lyrEps":-7.462884,"volumeRatio":0.769362,"shares":478911979,"dividePrice":4.1177,"high":175.365,"amplitude":0.025442,"preClose":171.57,"low":171,"week52Low":90,"pbRate":"4.00","psRate":"3.74","week52High":219.589,"institutionHeld":0,"latestPrice":172.25,"committee":-0.166348,"eps":-7.462884355980978,"divideRate":0.023905,"volume":603472,"delay":0,"ttmEps":-7.462884355980978,"open":172.8,"prevYearClose":170.408,"prevWeekClose":172.32,"prevMonthClose":171.57,"prevQuarterClose":114.74,"fiveDayClose":173.64,"twentyDayClose":128.83,"sixtyDayClose":99.47,"dividendPayoutRate":0.4488044711953849,"dividendGrowthYears":5,"dividendGrowthRate":0.003543182641490467,"fiveYearAvgDividendRate":0.018567360626050477},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CSL.AU\",params:#limit:5,,,undefined,":[{"date":"2026-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-09-10","defaultRemindTime":1788912000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-10-02","payableDate":"2026-09-10","currency":"USD","dateTimestamp":1788876000000,"payDate":"2026-10-02"},{"date":"2026-08-18","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787011200000,"name":null,"time":"","dateTimestamp":1786975200000,"actualEps":null},{"date":"2026-03-10","symbol":"CSL.AU","amount":1.3,"announcedDate":"2026-02-11","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2026-03-11","name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-04-09","payableDate":"2026-03-11","currency":"USD","dateTimestamp":1773061200000,"payDate":"2026-04-09"},{"date":"2026-02-11","symbol":"CSL.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770764400000,"name":null,"time":"","dateTimestamp":1770728400000,"actualEps":null},{"date":"2025-09-09","symbol":"CSL.AU","amount":1.62,"announcedDate":"2025-08-19","type":"dividend","lastAmount":null,"market":"AU","newRecordDate":"2025-09-10","defaultRemindTime":1757376000000,"name":"CSL LIMITED","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-10-03","payableDate":"2025-09-10","currency":"USD","dateTimestamp":1757340000000,"payDate":"2025-10-03"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CSL.AU\",market:\"AU\",,,undefined,":[{"executeDate":"2020-09-10","recordDate":"2020-09-11","paymentDate":"2020-10-09","value":1.469578,"currency":"AUD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-04-01","value":1.04,"currency":"USD"},{"executeDate":"2021-09-02","recordDate":"2021-09-03","paymentDate":"2021-09-30","value":1.062,"currency":"USD"},{"executeDate":"2022-03-07","recordDate":"2022-03-08","paymentDate":"2022-04-06","value":1.04,"currency":"USD"},{"executeDate":"2022-09-06","recordDate":"2022-09-07","paymentDate":"2022-10-05","value":1.062,"currency":"USD"}],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CSL.AU\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660176437","title":"CSL Limited - CSL Seqirus Expects Low Single Digit Revenue Growth in FY","url":"https://stock-news.laohu8.com/highlight/detail?id=2660176437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660176437?lang=en_us&edition=fundamental","pubTime":"2026-08-18 06:00","pubTimestamp":1787004010,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nPLXMQ2BQ8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BK7511","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431738","title":"3 ASX Dividend Stocks Paying Investors While They Wait","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431738","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431738?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:19","pubTimestamp":1786987170,"startTime":"0","endTime":"0","summary":"With central banks keeping policy paths in sharp focus and 10Y bond yields edging higher, income investors are being asked to work harder for dependable cash flow. That is where Dividend Powerhouses with 5%+ yields and solid coverage come into play, offering income potential while capital is deployed. These stocks are designed to pay you while you wait. This article walks through three standouts from the screener and explains what makes each one worth a closer look.\nThe three stocks below are...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-asx-dividend-stocks-paying-investors-while-they-wait","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","BK7501","GXDW","BK4585","VGFPF","BK4211","ISBC","PMDE","RGLO","BK7033","CBA.AU","QTOC","BK7508","VIG","SPHQ","BK7511","BK7067","DECU","BK7503","BK4588","CPU.AU","FEBU","VOTE","BK7157","BK7135","JOYT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659017849","title":"Accenture Stock And 2 More Dividend Shares Yielding Over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659017849","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659017849?lang=en_us&edition=fundamental","pubTime":"2026-08-15 16:22","pubTimestamp":1786782156,"startTime":"0","endTime":"0","summary":"Central banks in several countries are holding policy rates steady while inflation pressures remain uneven. That mix keeps bond yields and cash returns uncertain, which makes reliable income from equities more appealing. Dividend Powerhouses can offer regular cash payouts that do not depend on policy meetings every few months. This article walks through 3 stocks from the Dividend Powerhouses screener that currently offer 3%+ yields with a focus on coverage and stability.\nThe three stocks...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/accenture-stock-and-2-more-dividend-shares-yielding-over-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/accenture-stock-and-2-more-dividend-shares-yielding-over-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU0942090050.USD","IISV.AU","LU0323239441.USD","OZF.AU","LU0553294199.USD","LU1003077747.HKD","QFN.AU","XJO.AU","CBA.AU","VTHR","CSL.AU","IE000M9KFDE8.USD","LU2133065610.SGD","IMLC.AU","LU1585245621.USD","CHAT","LU1116320901.HKD","XKO.AU","QRE.AU","DACE.AU","LU0265550946.USD","BEAR.AU","SG9999014914.USD","LU1116320737.USD","LU0949170772.SGD","ARTY","ACN","VIG","IIGF.AU","BK4581","AIPO","GEAR.AU","QTOC","VAP.AU","EIGA.AU","OZR.AU","E200.AU","LU0545039389.USD","SLF.AU","SG9999014906.USD","IOZ.AU","LU0342679015.USD","GIVE.AU","ZYAU.AU","AGIX","BBOZ.AU","XAO.AU","VAS.AU","LU0738911758.USD","STW.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659124711","title":"3 Australian Dividend Powerhouses Offering 3% Yields In An Uncertain Rate Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659124711","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659124711?lang=en_us&edition=fundamental","pubTime":"2026-08-15 01:33","pubTimestamp":1786728821,"startTime":"0","endTime":"0","summary":"With global inflation still exerting pressure and central banks keeping policy options open, reliable income has fresh appeal for investors who want clarity in a foggy rate outlook. High quality dividend powerhouses, often called Dividend Aristocrats, can offer consistent cash flows when bond yields and currencies move around. This article highlights three stocks from our Dividend Powerhouses screener that deliver 3%+ yields with covered, growing payouts.\nThe stocks covered below are just a...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-powerhouses-offering-3-yields-in-an-un","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-powerhouses-offering-3-yields-in-an-un","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XJO.AU","BK4588","BK7511","AIPO","GEAR.AU","VTHR","CPU.AU","BK7501","GIVE.AU","OZR.AU","BK7508","BK7157","IIGF.AU","IOZ.AU","SLF.AU","XAO.AU","IMLC.AU","OZF.AU","BK7033","CSL.AU","BK7067","XKO.AU","AGIX","BEAR.AU","IISV.AU","BK4585","QFN.AU","STW.AU","BBOZ.AU","VIG","BK7503","E200.AU","VAP.AU","DACE.AU","CBA.AU","QRE.AU","VAS.AU","ZYAU.AU","CHAT","BK7135","QTOC","EIGA.AU","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659191065","title":"3 Dividend Stocks For Reliable Income When Cash Rates Feel Less Rewarding","url":"https://stock-news.laohu8.com/highlight/detail?id=2659191065","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659191065?lang=en_us&edition=fundamental","pubTime":"2026-08-14 09:27","pubTimestamp":1786670875,"startTime":"0","endTime":"0","summary":"With central banks holding interest rates at restrictive levels, government bond yields set the tone for income investors. Cash and short term debt now feel less rewarding once inflation and tax are factored in. Reliable dividends above 5% suddenly look more appealing as a way to target real income. This article highlights three stocks from the Dividend Powerhouses screener that offer high yields with coverage and stability.\nThe three stocks highlighted next are just a starting sample from...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-dividend-stocks-for-reliable-income-when-cash-rates-feel-l","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-dividend-stocks-for-reliable-income-when-cash-rates-feel-l","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4166","LU1051769294.HKD","LU1051768304.USD","LU1046231319.USD","SG9999017495.SGD","LU0738911758.USD","SG9999014880.SGD","LU1235294995.USD","LU1228905037.USD","BK4134","IE00BJJMRY28.SGD","LU0545039389.USD","IE00BFSS7M15.SGD","LU1585245621.USD","SGXZ23171101.USD","LU2211815571.USD","CSL.AU","LU0047713382.USD","LU0196876865.USD","IE00BSNM7G36.USD","LU1989772923.USD","LU2133065610.SGD","LU0342679015.USD","IE00B7KXQ091.USD","LU1668664300.SGD","LU1989772840.SGD","LU0553294199.USD","ACN","LU2348774022.SGD","KSPI","BK7501","BK7067","LU0157215616.USD","BK4533","LU1228905540.USD","LU1506573853.SGD","LU0545562505.USD","LU1515016050.SGD","LU1861217088.USD","IE00BJJMRX11.SGD","LU2153592121.USD","SGXZ31699556.SGD","BK4581","IE000M9KFDE8.USD","LU1116320901.HKD","LU0868494617.USD","LU1003077747.HKD","SG9999014898.SGD","SG9999018857.SGD","BK4566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659919824","title":"Top ASX Dividend Stocks For August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2659919824","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659919824?lang=en_us&edition=fundamental","pubTime":"2026-08-14 03:09","pubTimestamp":1786648151,"startTime":"0","endTime":"0","summary":"As the Australian market anticipates a soft opening with S&P/ASX 200 futures down, global economic factors such as the recent US inflation data and oil supply challenges continue to shape investor sentiment. In this climate, dividend stocks can offer a measure of stability and income potential, making them an attractive option for investors seeking consistent returns amidst fluctuating market conditions.","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/top-asx-dividend-stocks-for-august-2026","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/top-asx-dividend-stocks-for-august-2026","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VOTE","XJO.AU","PMDE","QFN.AU","FID.AU","VAS.AU","XKO.AU","EIGA.AU","BEAR.AU","ZYAU.AU","OCL.AU","CWP.AU","QRE.AU","GEAR.AU","GIVE.AU","JIN.AU","CSL.AU","IISV.AU","BK7016","KSL.AU","BK7101","BK7078","SLF.AU","E200.AU","IMLC.AU","IIGF.AU","MFF.AU","BK4588","BK7067","PPC.AU","SDF.AU","BK7145","BK7062","HDV","AUI.AU","DECU","OZF.AU","VIG","BK7501","VGFPF","IOZ.AU","BK7511","OZR.AU","BBOZ.AU","XAO.AU","DACE.AU","VAP.AU","STW.AU","BK7135","EQT.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658911015","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658911015","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658911015?lang=en_us&edition=fundamental","pubTime":"2026-08-11 23:57","pubTimestamp":1786463857,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 11 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260811:nL4N44815K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0985320562.USD","LU1829250122.USD","LU0820561818.USD","LU1116320737.USD","SGXZ99366536.SGD","BK4585","LU2360106947.USD","LU2347655073.USD","LU2361044865.SGD","BK7067","IE00B19Z9P08.USD","LU1037948897.HKD","SGXZ51526630.SGD","GB00BDT5M118.USD","LU0471298694.HKD","IE00B894F039.SGD","LU1035775433.USD","IE00B19Z3B42.SGD","LU0965509101.SGD","LU1670710661.SGD","TMED","SG9999018857.SGD","LU1670628061.USD","LU0265550946.USD","ELIL","LU0310800379.SGD","LU1032466523.USD","LU2592432038.USD","LU2236285917.USD","LU2324357040.USD","LU0345770993.USD","SG9999014559.SGD","LLY","LU0426417589.USD","LU1244550221.USD","LU0456855351.SGD","LLYX","THNR","LU0058720904.USD","IE00B19Z3581.USD","LU0053666078.USD","IE00BLSP4452.SGD","LU0320765059.SGD","LU2168564495.EUR","LU2133065610.SGD","LU1127390331.HKD","LU2108987350.USD","LU0211328371.USD","IE00BZ1G4Q59.USD","BK4533","CURE","LU0545562505.USD","LU0942090050.USD","BK4568","LU2023251221.USD","LU0267386448.USD","LU0289961442.SGD","LU1145028129.USD","LU0661504455.SGD","LLYZ","IE00BJLML261.HKD","LU2756315664.SGD","LU0868494617.USD","LU0203201768.USD","SG9999014567.USD","IE0002270589.USD","BIB","LU1983299246.USD","GSKH","LU2237443895.HKD","LU2125909247.SGD","SG9999002224.SGD","LU0096364046.USD","IBBQ","LU2168564065.EUR","LU0648001328.SGD","LU2028103732.USD","LU0471298777.SGD","LU0198837287.USD","LU1934455194.USD","BK4550","LU0980610538.SGD","LU0353189763.USD","LU0070217475.USD","LU0234572021.USD","BK4578","LU2471134879.HKD","LU1929549753.HKD","LU2063271972.USD","LU1720051108.HKD","BBH","BK4581","LU0069063385.USD","LU2089283258.USD","LU1571399168.USD","LU0792757196.USD","IE00BN29S564.USD","JNJ","LU0237698245.USD","NVO","BK4592","TRUH","LU0545039389.USD","LU1059921491.USD","ABBV","IE000WAW04H5.SGD","LU2264538146.SGD","MEDI","LU2552382132.HKD","LU0211327993.USD","LU0786609619.USD","LU1989772840.SGD","LU2462157665.USD","XLV","LU1914381329.SGD","SG9999018865.SGD","LU2023250330.USD","IHE","LU1232071149.USD","LU1699723380.USD","LU2237443978.SGD","MRK","LU0079474960.USD","LU1917777945.USD","LU0225283273.USD","LU2596442595.SGD","LU1035773651.USD","LU1023059063.AUD","SNY","SG9999014880.SGD","LU0122379950.USD","LU2237443382.USD","IE00B4R5TH58.HKD","IE00BFSS7M15.SGD","IE0001KFT4U8.USD","IE00B42XCP33.USD","LU0345769128.USD","LU0882574139.USD","LU1291159041.SGD","SG9999014575.USD","IE00B7KXQ091.USD","LU2168564149.EUR","LU2361045086.USD","IE00BWXC8680.SGD","LU1506573853.SGD","BK7511","LU1121112475.USD","LU0787776722.HKD","LU1718418525.SGD","IE00BN8TJ469.HKD","LU1066053197.SGD","LU0154236417.USD","LU0234570918.USD","LU0321505868.SGD","LU2125154935.USD","RHHBY","LU2471134796.USD","LU2462591350.SGD","LU1868837136.USD","LU0672654240.SGD","SG9999014542.SGD","IE00BSNM7G36.USD","LU0061475181.USD","LU1934455863.HKD","LU2750360641.GBP","IE0000B7K699.USD","LU1066051498.USD","LU0820561909.HKD","LU2271345857.HKD","IE00BJJMRZ35.SGD","LU0964807845.USD","IE00B19Z9Z06.USD","LU0210528500.USD","LU0057025933.USD","LU1934455277.USD","LU1989771016.USD","LU2491049909.HKD","LU0985481810.HKD","LU0124676726.USD","OZEM","LU1988902786.USD","LU1974910355.USD","LU2896262040.SGD","LU0943347566.SGD","LU2487616109.SGD","LU0385154629.USD","LU0738911758.USD","IE00BFXG1179.USD","LU0320765646.SGD","LU2357305700.SGD","LU1228905037.USD","LU2360032135.SGD","LU2213496289.HKD","LU1074936037.SGD","LU0130102774.USD","LU2505996509.AUD","WDNA","AZN","LU2129689514.USD","SG9999001440.SGD","IE00BVYPNW00.USD","LU0128525929.USD","LU1069347547.HKD","IE0005OL40V9.USD","LU1093756168.USD","GSK.UK","LU0225771236.USD","LU0912757837.SGD","IE00BK4W5L77.USD","NVOH","LU0795875086.SGD","NVOX","LU0256863811.USD","LU1261432733.SGD","LU0130517989.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0158827948.USD","LU0683600562.USD","LU1032955483.USD","LU1935042991.SGD","BIIB","LU2023250504.SGD","BK4559","LU2417539215.USD","MEDX","LU1585245621.USD","LU1941712348.USD","GDOC","LU1551013342.USD","LU1043141396.HKD","LU2552382058.USD","LU2129689431.USD","LU0203347892.USD","LU0949170772.SGD","BK7508","LU0256863902.USD","SGXZ31699556.SGD","PPH","CANC","LU0823434740.USD","IE0004445015.USD","IE00BBT3K403.USD","PFE","GSK","LU1894683348.USD","SG9999015952.SGD","SG9999014906.USD","LU1674673428.USD","LU2430703178.SGD","SG9999015945.SGD","LU1629891620.HKD","LU0882574055.USD","LU2265009873.SGD","LU2433249047.HKD","LU2111349929.HKD","IE0009355771.USD","LU0689626769.HKD","LU0203345920.USD","LU0823416689.USD","AMGN","LU1496350502.SGD","LU0203202063.USD","IE00B7SZLL34.SGD","LU1244550494.USD","IE0034235303.USD","LU0708994859.HKD","LU1061106388.HKD","SG9999015358.SGD","LU2430703095.HKD","LU0070302665.USD","GILD","FHLC","LU1839511570.USD","IE00BFTCPJ56.SGD","LU2347655156.SGD","PAWZ","LU0306807586.USD","LU0859254822.USD","LU2237443465.HKD","LU2023250843.SGD","IE000MB6IJN5.SGD","IE00BKDWB100.SGD","SGXZ80539844.SGD","JDOC","BK4516","LU2087621335.USD","IE00B1XK9C88.USD","LU1196500208.SGD","LU0170899867.USD","LU0965509283.SGD","LU1551013425.SGD","IE00B775H168.HKD","LU0306806265.USD","LU0689472784.USD","LU1712237335.SGD","LU1267930730.SGD","LU0994945656.USD","LU0029864427.USD","LU0097036916.USD","LU1623119135.USD","ILDR","IXJ","LU0114720955.EUR","BK4532","IE00BJJMRX11.SGD","LU0726765562.USD","IBB","LU1116320901.HKD","IE00BFSS8Q28.SGD","LU1923622614.USD","LU0109391861.USD","LU0174119429.USD","IE000F7OJYX1.SGD","AZNH","VHT","FTXH","03165","LU0345770308.USD","LU2357627491.SGD","LU1674673691.USD","BK4534","LU1804176565.USD","LU1868837300.USD","SG9999015986.USD","IE000BZT7R73.USD","LU2361044949.HKD","IE00BKVL7J92.USD","IE000SO60NU8.SGD","LU1720051017.SGD","AGNG","IE00BK4W5M84.HKD","LU1430594728.SGD","BK4504","LU0133085943.USD","LU2125909593.SGD","LU2746668461.USD","LU1548497426.USD","LU0289739343.SGD","LU1670711123.USD","LU1883839398.USD","LU1894683264.USD","LU0320765489.SGD","LU0965508806.USD","BK4139","LU2505996681.GBP","SG9999003800.SGD","LU2112291526.USD","IE00BVYPNV92.GBP","LU1868836757.USD","SG9999001176.USD","SG9999011175.SGD","LU2491050154.USD","SG9999017495.SGD","BMY","IE0002141913.USD","IE00BDGV0183.EUR","LU1066051811.HKD","LU0708995401.HKD","LU0208291251.USD","BK4599","CSL.AU","LU2211815571.USD","LU2468319806.SGD","LU0426412945.USD","LU2471134952.CNY","LU0553294199.USD","BK4588","LU1069344957.HKD","LU0823434583.USD","SG9999015978.USD","LU1228905540.USD","LU0354030511.USD","IE00B4JS1V06.HKD","IE000M9KFDE8.USD","IYH","LU1732799900.SGD","LU1003077747.HKD","LU1093756325.SGD","LU2471134523.USD","SG9999014898.SGD","LU2168564222.USD","LU0323591593.USD","LU1732800096.USD","LU1267930573.SGD","NVS","LU1267930813.SGD","SG9999001176.SGD","LU2750360997.AUD","LU0353189680.USD","LU1778281490.HKD","LU2430703251.USD","LLII","LU2602419157.SGD","LU2125154778.USD","LU2461242641.AUD","LU1868836591.USD","LU2552382215.SGD","IE00BLSP4239.USD","LU0289739699.SGD","LU2106854487.HKD","LU1162221912.USD","LU2242646821.SGD","LU2129689605.HKD","LU2089984988.USD","LU0417517546.SGD","04332","LU2237443549.SGD","BK4566","LU0320765992.SGD","LU0795875169.SGD","LU0640476718.USD","LU0395794307.EUR","LU1221951046.USD","LU0889566641.SGD","RXL","LU1323610961.USD","LU1221951129.SGD","LU0861579265.USD","PJP","LU0466842654.USD","BK4583","LU1670711040.USD","LU1066051225.USD","LU0158827781.USD","LU0820562030.AUD","LU0889565916.HKD","LU1280957306.USD","SG9999014914.USD","LU0266013472.USD","LU2242652126.USD","LU0868494708.USD","BK4007","LU2756315318.SGD","LU0345769631.USD","IE00B3PB1722.GBP","LU1064131342.USD","LU0511384066.AUD","LU1868836914.USD","LU0072461881.USD","SGXZ57979304.SGD","LU1043141123.HKD","LU2237438978.USD","TBXU","IE00BJT1NW94.SGD","LU0098860793.USD","LU1037948541.HKD","ELIS","LU0321505439.SGD","IE00B3T34201.USD","LU0238689110.USD","LU2456880835.USD","LU1670710588.SGD","LU2491050071.SGD","SG9999002232.USD","LU1979441026.SGD","LU1670627923.USD","LU2746668974.SGD","LU0477156953.USD","LU0006306889.USD","LU1057294990.SGD","MHIP","SG9999015341.SGD","BK7501","LU1201861249.SGD","LU1496350171.SGD","LU0432979614.USD","LU2168563687.JPY","LU0162691827.USD","LU2087625088.SGD","SG9999013999.USD","IE00B1BXHZ80.USD","LU0965509010.AUD","LU1366192091.USD","LU2237443622.USD","LU0354030438.USD","LU0316494557.USD","HRTS","LU1244550577.SGD","IE00BJJMRY28.SGD","IE00BKPKM429.USD","LU0310799852.SGD","LU1267930490.SGD","LU1989772923.USD","LU0225284248.USD","LU0472753341.HKD","LU0211331839.USD","BMED","PBE","SGXZ81514606.USD","LU2403377893.USD","GLAM","IE0004445239.USD","LU0094547139.USD","LU1941712264.USD","LU2089284900.SGD","LU0106261372.USD","LU1814569148.SGD","LU0210536198.USD","IE00BGHQF631.EUR","LU0265550359.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912416","title":"Australian Dividend Stocks With 3% Yields That Deserve A Closer Look","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912416","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658912416?lang=en_us&edition=fundamental","pubTime":"2026-08-11 22:30","pubTimestamp":1786458600,"startTime":"0","endTime":"0","summary":"Central banks are still holding interest rates high to deal with stubborn inflation in areas like housing and transport, which keeps income focused investors on edge. Reliable cash flows suddenly matter a lot more. That is where the Dividend Powerhouses screener comes in, with stocks offering 3%+ yields that are covered and growing. This article highlights three of the strongest candidates from that list.\nThe three stocks below are just a starting sample from this idea. The full screen...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-3-yields-that-deserve-a-clos","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/australian-dividend-stocks-with-3-yields-that-deserve-a-clos","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["FGDL","GDXJ","DULL","GLDM","GLTR","GOLY","XJO.AU","XKO.AU","BTGD","PHYS","CEF","XAO.AU","GEAR.AU","QBE.AU","GDXD","SHNY","DGP","BEGS","UGL","DBC","XME","DZZ","IMLC.AU","PPI","GBUG","CSL.AU","SGDM","VIG","GLDY","IAUM","EVN.AU","GDXY","UYM","GDX","JDST","GLL","IAUI","USG","AAAU","RING","PICK","SGOL","BEAR.AU","GDXU","BAR","JNUG","GOAU","IAU","DUST","OUNZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658931607","title":"Global Drugmakers Invest Billions to Boost US Presence","url":"https://stock-news.laohu8.com/highlight/detail?id=2658931607","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658931607?lang=en_us&edition=fundamental","pubTime":"2026-08-10 21:16","pubTimestamp":1786367800,"startTime":"0","endTime":"0","summary":"FACTBOX-Global drugmakers invest billions to boost US presenceAug 10 (Reuters)-Global drugmakers are expanding their U.S. footprint, pledging billions of dollars to ramp up manufacturing capacity and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260810:nL4N4470VR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014559.SGD","LU0265550946.USD","LU0472753341.HKD","IE000MB6IJN5.SGD","LU0545039389.USD","LU1201861249.SGD","LU1829250122.USD","LU0689626769.HKD","LU1032466523.USD","IE00B7KXQ091.USD","BK4532","LU1941712264.USD","LU0321505439.SGD","LU0225283273.USD","LU0965509283.SGD","LU0109394709.USD","LU0203347892.USD","LU1720051108.HKD","LU0795875086.SGD","LU2462157665.USD","BK4578","LU1934455863.HKD","LLYX","SG9999015978.USD","LU1674673428.USD","IE0000B7K699.USD","LU0114720955.EUR","LU0426417589.USD","LU0237698245.USD","LU0211327993.USD","LU1974910355.USD","LU2237443895.HKD","LU2461242641.AUD","LU0820561909.HKD","LU1291159041.SGD","LU1623119135.USD","LU0889566641.SGD","IBBQ","LU2129689431.USD","LU0306807586.USD","LU2211815571.USD","LU2552382215.SGD","LU2112291526.USD","LU1323610961.USD","IE00B1XK9C88.USD","BK7067","BK7511","LU2471134523.USD","BK4550","TMED","HRTS","IE00BSNM7G36.USD","LU1989772840.SGD","LU0672654240.SGD","LU2023251221.USD","LU1935042991.SGD","LU0868494617.USD","PAWZ","TBXU","LU0353189763.USD","LU1670711040.USD","LU1894683264.USD","GSKH","SGXZ31699556.SGD","SG9999018857.SGD","IE00B3T34201.USD","BK4592","LU2430703095.HKD","LU0385154629.USD","LU2471134952.CNY","IE00B2B36J28.USD","LU2023250843.SGD","LU0708995401.HKD","JNJ","LU1366192091.USD","LU2491050154.USD","LU0210536198.USD","LU2487616109.SGD","LU1145028129.USD","IE00B894F039.SGD","LU2596442595.SGD","LU1280957306.USD","LU1929549753.HKD","IE00BN8TJ469.HKD","LU2896262040.SGD","IE000M9KFDE8.USD","LU2357305700.SGD","LU0985320562.USD","SG9999015945.SGD","SG9999014906.USD","LU1066051811.HKD","LU1989771016.USD","LU2265009873.SGD","LU0942090050.USD","LU0648001328.SGD","LU2430703178.SGD","LU2361044865.SGD","GB00BDT5M118.USD","AMGN","LU2129689514.USD","SG9999013999.USD","LU1674673691.USD","LU0354030511.USD","LU0823434740.USD","LU0965509010.AUD","LU1066051225.USD","LU1670710661.SGD","MEDI","SG9999014898.SGD","TRUH","IE00BFSS7M15.SGD","LU1035775433.USD","IE00BKDWB100.SGD","LU1699723380.USD","LU1914381329.SGD","LU1221951129.SGD","LU1868836914.USD","LU0130102774.USD","IE00BJJMRX11.SGD","IE00BK4W5L77.USD","LU0787776722.HKD","LU0795875169.SGD","LU2462591350.SGD","LU2756315318.SGD","AGNG","LU2403377893.USD","LU0124676726.USD","SG9999014575.USD","RXL","SGXZ81514606.USD","LU2106854487.HKD","IE0001KFT4U8.USD","LU1221951046.USD","LU2750360997.AUD","LU0792757196.USD","LU0708994859.HKD","LU2360106947.USD","LU0106261372.USD","LU2491049909.HKD","LLII","JDOC","LU0267386448.USD","IE00BKVL7J92.USD","LU1267930573.SGD","LU2028103732.USD","BK4588","LU1064131342.USD","GSK","LU0823416689.USD","LU1496350502.SGD","PJP","LU0683600562.USD","LU0069063385.USD","LU0738911758.USD","LU0456855351.SGD","BK4516","GLAM","LU0823434583.USD","THNR","LU1232071149.USD","LU1979441026.SGD","LU2129689605.HKD","LU1162221912.USD","LU1629891620.HKD","LU2417539215.USD","SG9999001176.USD","IE0002141913.USD","LU0320765059.SGD","LU0964807845.USD","LU1732800096.USD","LU1244550221.USD","LU2357627491.SGD","SG9999014542.SGD","LU0210528500.USD","LU1804176565.USD","LU0198837287.USD","LU1923622614.USD","LU0861579265.USD","LU1814569148.SGD","LU1551013342.USD","IE0004445015.USD","LU1894683348.USD","CANC","LU1037948541.HKD","LU0170899867.USD","LU1934455277.USD","VHT","LU2213496289.HKD","LU2237443622.USD","IE00B19Z9P08.USD","IE00BVYPNV92.GBP","LU0882574055.USD","SG9999011175.SGD","BK4585","IE00B1BXHZ80.USD","LU0345769128.USD","LU2089283258.USD","IE00BWXC8680.SGD","IE00BJT1NW94.SGD","SG9999001440.SGD","ABBV","LU2237443382.USD","LU2505996681.GBP","SG9999001176.SGD","IE000WAW04H5.SGD","LU0006306889.USD","LU2505996509.AUD","LU1121112475.USD","IE00BGHQF631.EUR","LU0511384066.AUD","LU1883839398.USD","LU0158827781.USD","IE0005OL40V9.USD","LU2491050071.SGD","IE00B42XCP33.USD","LU1868837300.USD","LU0353189680.USD","IE000SO60NU8.SGD","SG9999002232.USD","LU2242646821.SGD","LU0203345920.USD","LU1043141396.HKD","LU2125909247.SGD","LU2023250330.USD","SG9999018865.SGD","LU2087621335.USD","IE00BVYPNW00.USD","SG9999014880.SGD","LU1868836757.USD","IE00BKPKM429.USD","BK4534","LU0432979614.USD","IE00B19Z9Z06.USD","LU2347655156.SGD","LU2756315664.SGD","LU0158827948.USD","LU2063271972.USD","LU1720051017.SGD","LU2552382058.USD","SG9999015341.SGD","LU0889565916.HKD","FHLC","LU2125909593.SGD","ELIL","LU2168564065.EUR","FTXH","BIB","PPH","LU1917777945.USD","LU0234570918.USD","LU0057025933.USD","LU1506573853.SGD","IYH","LU1732799900.SGD","LU0203201768.USD","IE0004445239.USD","LU2361044949.HKD","LU2168563687.JPY","IE00BJJMRY28.SGD","LU0265550359.USD","LU0786609619.USD","LU0053666078.USD","LU1551013425.SGD","LU0545562505.USD","LU1069347547.HKD","LU2168564149.EUR","LU0122379950.USD","IE000F7OJYX1.SGD","PBE","LU2237438978.USD","LU2750360641.GBP","LU2471134879.HKD","LU1093756325.SGD","LU1868837136.USD","LU2746668461.USD","LU2471134796.USD","LU2552382132.HKD","LU2237443549.SGD","IE00B4R5TH58.HKD","CSL.AU","LU1061106388.HKD","LU0162691827.USD","LU1196500208.SGD","BK4566","LU0094547139.USD","IE00BZ1G4Q59.USD","LU1718418525.SGD","LU0323591593.USD","ELIS","LU2236285917.USD","BK4533","BMY","LU2089284900.SGD","IE00B3PB1722.GBP","LU0980610538.SGD","LU2433249047.HKD","LU1116320737.USD","LU1069344957.HKD","LU0912757837.SGD","IE00BDGV0183.EUR","LU2168564495.EUR","SG9999014914.USD","MHIP","LU2271345857.HKD","LU1983299246.USD","LU0211331839.USD","SGXZ51526630.SGD","LU2087625088.SGD","LLYZ","LU2237443465.HKD","LU2361045086.USD","IE00B7SZLL34.SGD","PFE","LU0868494708.USD","IBB","LU1244550577.SGD","MEDX","LU0553294199.USD","LU2237443978.SGD","LU0058720904.USD","LU1003077747.HKD","LU2456880835.USD","LU0943347566.SGD","LU1228905037.USD","LU0097036916.USD","LU0256863902.USD","IE00B775H168.HKD","LU2023250504.SGD","LU1059921491.USD","LU2089984988.USD","LU0426412945.USD","BMED","LU2468319806.SGD","LU0471298694.HKD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1988902786.USD","SG9999003800.SGD","SG9999002224.SGD","LU1267930490.SGD","LU0225771236.USD","BK4504","LU0345769631.USD","IE00BLSP4452.SGD","IE00BJLML261.HKD","LU2168564222.USD","LU2360032135.SGD","LU1228905540.USD","LU2133065610.SGD","CURE","LU0266013472.USD","IXJ","LLY","LU0726765562.USD","LU1127390331.HKD","BK4599","LU0640476718.USD","IE00BFSS8Q28.SGD","SG9999017495.SGD","BK4139","IE0009355771.USD","IE00B4JS1V06.HKD","BK4581","MRK","LU1066051498.USD","LU0096364046.USD","LU1571399168.USD","SGXZ57979304.SGD","IE000BZT7R73.USD","BK4007","IE00BK4W5M84.HKD","LU1868836591.USD","SGXZ99366536.SGD","LU0238689110.USD","IHE","LU1074936037.SGD","LU0310800379.SGD","LU0070217475.USD","GSK.UK","LU0211328371.USD","LU0320765646.SGD","LU0477156953.USD","LU1267930813.SGD","LU0310799852.SGD","IE00B19Z3581.USD","LU0820561818.USD","LU0203202063.USD","IE0034235303.USD","SG9999015358.SGD","WDNA","LU0174119429.USD","SGXZ80539844.SGD","LU0471298777.SGD","XLV","LU1548497426.USD","LU1261432733.SGD","LU0070302665.USD","LU0321505868.SGD","BK7508","LU2108987350.USD","LU0109391861.USD","LU1934455194.USD","LU0098860793.USD","LU0965509101.SGD","IE00B19Z3B42.SGD","LU1585245621.USD","SG9999014567.USD","LU0320765489.SGD","LU2430703251.USD","LU0985481810.HKD","LU1496350171.SGD","LU1093756168.USD","IE0002270589.USD","LU0661504455.SGD","AZNH","LU0208291251.USD","GDOC","LU0061475181.USD","GILD","BK4568","LU0256863811.USD","LU1670711123.USD","LU0965508806.USD","LU0289739699.SGD","BK4583","04332","LU0316494557.USD","LU1712237335.SGD","LU0395794307.EUR","LU2746668974.SGD","LU0820562030.AUD","LU2111349929.HKD","ILDR","LU2602419157.SGD","LU0949170772.SGD","BIIB","LU0225284248.USD","LU2125154778.USD","BBH","AZN","LU1670628061.USD","IE00BJJMRZ35.SGD","SG9999015986.USD","LU0133085943.USD","LU1057294990.SGD","LU1035773651.USD","LU2242652126.USD","LU2592432038.USD","LU0128525929.USD","LU0345770993.USD","BK7501","LU1670627923.USD","LU0859254822.USD","LU1670710588.SGD","LU1066053197.SGD","IE00BLSP4239.USD","LU0029864427.USD","LU0882574139.USD","LU0354030438.USD","LU2347655073.USD","LU0289961442.SGD","LU0289739343.SGD","LU0072461881.USD","LU1430594728.SGD","BK4559","LU0130517989.USD","LU0689472784.USD","LU2264538146.SGD","IE00BBT3K403.USD","LU0345770308.USD","LU0466842654.USD","LU2125154935.USD","LU0306806265.USD","IE00BN29S564.USD","SG9999015952.SGD","LU1244550494.USD","LU1116320901.HKD","IE00BFXG1179.USD","LU1032955483.USD","LU0994945656.USD","LU2324357040.USD","LU1037948897.HKD","LU1043141123.HKD","OZEM","LU1839511570.USD","LU1267930730.SGD","LU1941712348.USD","LU1989772923.USD","LU0417517546.SGD","LU1778281490.HKD","LU0234572021.USD","LU0320765992.SGD","LU0079474960.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658316209","title":"ASX Dividend Stocks With 5% Yields That Stand Out Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2658316209","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658316209?lang=en_us&edition=fundamental","pubTime":"2026-08-10 20:25","pubTimestamp":1786364745,"startTime":"0","endTime":"0","summary":"With central banks keeping policy rates steady and traders pulling back expectations for rapid US hikes after softer jobs data, dependable income from shares has fresh appeal. Cash yields can change quickly. Reliable dividend streams from companies screened for yields above 5% that appear well covered, growing and stable can stand out. This article walks through three Dividend Powerhouses and why they may deserve a spot on your watchlist.\nThe three stocks covered below are only a starting...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/asx-dividend-stocks-with-5-yields-that-stand-out-right-now","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/asx-dividend-stocks-with-5-yields-that-stand-out-right-now","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XME","BK7501","UYM","BK7506","BK7508","BK7511","BK7067","QBE.AU","BK4535","BK7104","BK7034","CSL.AU","EVN.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658601483","title":"ASX Midday Sector Update: Healthcare Stocks Advance, Financial Sector Struggles","url":"https://stock-news.laohu8.com/highlight/detail?id=2658601483","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658601483?lang=en_us&edition=fundamental","pubTime":"2026-08-10 10:51","pubTimestamp":1786330282,"startTime":"0","endTime":"0","summary":"Healthcare stocks advanced more than 1% at midday Monday.CSL (ASX:CSL) gained 1% in recent trade.On the flip side, the financial sector struggled, shedding more than 2%.Commonwealth Bank of Australia (ASX:CBA) shares fell past 2% in recent trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CBA.AU","BK7501","LU0128526141.USD","XLV","LABU","BK4137","XBI","BK4588","LU0029874061.USD","BK4585","BK4581","BK7135","CSL.AU","BK7508","BK7067","BK7511","HCSG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658606993","title":"Carlisle Companies (CSL) Could Be 6% Undervalued After Guidance Raise And Buyback Boost","url":"https://stock-news.laohu8.com/highlight/detail?id=2658606993","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658606993?lang=en_us&edition=fundamental","pubTime":"2026-08-10 08:20","pubTimestamp":1786321245,"startTime":"0","endTime":"0","summary":"Carlisle Companies dividend hike and guidance raise put capital returns in focus\nCarlisle Companies (CSL) has drawn fresh attention after reporting record second quarter results, raising full year revenue guidance to mid single digit growth and lifting its 2026 share repurchase target to $1.2b.\nAt the same time, the Board approved a 14% increase in the regular quarterly dividend to $1.25 per share, or $5 on an annualized basis. The dividend is payable on September 1, 2026, to shareholders of...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3061000-choice1-main-header/1585186603448"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-could-be-6-undervalued-after-guidance","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nyse-csl/carlisle-companies/news/carlisle-companies-csl-could-be-6-undervalued-after-guidance","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","BK4086","BK7511","BK7501","LU1169590202.USD","CSL","LU1169589451.USD","SGXZ23171101.USD","LU0728928796.USD","SG9999004303.SGD","CSL.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658762016","title":"3 Dividend Powerhouses for More Reliable Income in Volatile Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2658762016","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658762016?lang=en_us&edition=fundamental","pubTime":"2026-08-09 07:37","pubTimestamp":1786232240,"startTime":"0","endTime":"0","summary":"With global government bond yields swinging on every new inflation print, income investors are feeling the squeeze. Reliable bond income now looks less predictable, yet cash still loses ground when prices rise. That is where high quality dividend powerhouses can help. This article breaks down three stocks from our Dividend Powerhouses screener that combine 5%+ yields with covered, growing payouts, helping you aim for steadier income from strong businesses.\nThe three dividend powerhouses...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-dividend-powerhouses-for-more-reliable-income-in-volatile","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-dividend-powerhouses-for-more-reliable-income-in-volatile","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7104","CSL.AU","VIG","EVN.AU","BK7501","UYM","BK7511","QBE.AU","BK4585","BK4588","XME","BK7067","BK7508","BK7034","BK4535","BK7506"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657400336","title":"3 Australian Dividend Stocks Paying Over 5% That Income Investors May Want To Check","url":"https://stock-news.laohu8.com/highlight/detail?id=2657400336","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657400336?lang=en_us&edition=fundamental","pubTime":"2026-08-07 20:32","pubTimestamp":1786105954,"startTime":"0","endTime":"0","summary":"With global central banks holding policy rates high as inflation pressures linger, cash in the bank can feel stuck while prices keep rising. Reliable dividends over 5% start to look more appealing when income is hard to grow through interest alone. This article walks through three dividend powerhouses from the 3%+ Yield screener that combine higher yields with coverage and stability to help anchor a long term portfolio.\nThe three stocks in this article are just a starting sample, and the full...","market":"nz","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-stocks-paying-over-5-that-income-inves","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/3-australian-dividend-stocks-paying-over-5-that-income-inves","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["CSL.AU","AAAU","DULL","GDX","JNUG","DUST","GOLY","UGL","IAU","USG","SGDM","UYM","XAO.AU","SGOL","SPHQ","IAUM","IAUI","GDXY","RING","DECU","GOAU","GLTR","XJO.AU","PPI","VOTE","QBE.AU","GBUG","VIG","BTGD","BEGS","BAR","JDST","GDXU","GLDM","CEF","XME","DBC","GDXJ","FGDL","EVN.AU","PHYS","SHNY","XKO.AU","OUNZ","DGP","GDXD","ISBC","DZZ","PICK","GLL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657615916","title":"Pediatric ANDEMBRY Phase 3b Success Might Change The Case For Investing In CSL (ASX:CSL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657615916","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657615916?lang=en_us&edition=fundamental","pubTime":"2026-08-07 14:40","pubTimestamp":1786084840,"startTime":"0","endTime":"0","summary":"CSL has reported positive top-line Phase 3b results for ANDEMBRY (garadacimab-gxii) in children aged 2 to 11 years with hereditary angioedema, showing a safety profile consistent with earlier studies and treatment responses that kept most participants attack-free over 12 months.\nThis progress in extending ANDEMBRY’s use to younger pediatric patients highlights CSL’s push to deepen its presence in rare disease prophylaxis through factor XIIa inhibition.\nWe’ll now examine how the positive...","market":"us","thumbnail":"https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/881503-main-header/1585186619618"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/pediatric-andembry-phase-3b-success-might-change-the-case-fo","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-csl/csl-shares/news/pediatric-andembry-phase-3b-success-might-change-the-case-fo","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999004303.SGD","BK4086","BK7508","BK7067","CSL.AU","LU1169589451.USD","SGXZ23171101.USD","BK7511","BK7501","CSL","LU0728928796.USD","LU1169590202.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657662564","title":"CSL Says European Commission Revokes Marketing Authorization for Tavneos","url":"https://stock-news.laohu8.com/highlight/detail?id=2657662564","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657662564?lang=en_us&edition=fundamental","pubTime":"2026-08-07 08:24","pubTimestamp":1786062287,"startTime":"0","endTime":"0","summary":"CSL  and Vifor Fresenius Medical Care Renal Pharma said the European Commission revoked the marketing authorization for the Tavneos drug following a recommendation from the European Medicine Agency's Committee for Medicinal Products for Human Use , according to a Thursday statement.Tavneos was developed as a treatment for adults with the main forms of ANCA-associated vasculitis, a potentially life-threatening disease where the immune system mistakenly attacks the body's own blood vessels.The marketing authorization was revoked due to concerns related to data handling in a phase 3 trial before approval was granted, with the CHMP concluding that a positive benefit-risk balance for the drug could no longer be established.\"While we are disappointed by the decision, we respect the outcome of the regulatory process and are committed to implementing it in full,\" CSL and Vifor Fresenius said.Tavneos will no longer be available for prescribing in the European Union and European Economic Area co","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SG9999004303.SGD","BK4086","BK4087","BK7508","BK7067","CSL.AU","LU1169589451.USD","SGXZ23171101.USD","BK7501","BK7511","CHMP","CSL","LU0728928796.USD","LU1169590202.USD","EPV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657657060","title":"Arcturus Q2 Revenue Falls Sharply on CSL Seqirus Deal End","url":"https://stock-news.laohu8.com/highlight/detail?id=2657657060","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657657060?lang=en_us&edition=fundamental","pubTime":"2026-08-07 04:12","pubTimestamp":1786047154,"startTime":"0","endTime":"0","summary":"Arcturus Q2 revenue falls sharply on CSL Seqirus deal endOverviewMessenger RNA medicines company's Q2 revenue fell sharply yr/yr due to CSL Seqirus collaboration terminationQ2 net loss widened yr/yr, ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nL1N4431D1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4139","MRNY","IDNA","BK7508","BK4551","MRNA","BK4548","BK4568","BK7511","BK7067","GNOM","WDNA","BK4534","BK4501","ARCT","BK4533","BK7501","CSL.AU","MRNX","BK4585","LGHT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657550279","title":"EU Revokes Marketing Authorisation for CSL-Partnered Tavneos in EU, EEA","url":"https://stock-news.laohu8.com/highlight/detail?id=2657550279","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657550279?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:20","pubTimestamp":1785997251,"startTime":"0","endTime":"0","summary":"EU revokes marketing authorisation for CSL-partnered TAVNEOS in EU, EEAEU regulators revoked the marketing authorization for TAVNEOS (avacopan), removing it from prescribing across the EU and EEA.The ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL2Gc2r7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7508","BK7067","BK7501","CSL.AU","BK7511"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502897","title":"CSL Ltd - European Commission Adopts Decision to Revoke Marketing Authorisation for Tavneos in the European Union and European Economic Area Countries","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502897","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502897?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:01","pubTimestamp":1785996070,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44225J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7067","CSL.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657502392","title":"CSL Ltd - Tavneos Will no Longer be Available for Prescribing in the EU and Eea","url":"https://stock-news.laohu8.com/highlight/detail?id=2657502392","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657502392?lang=en_us&edition=fundamental","pubTime":"2026-08-06 14:01","pubTimestamp":1785996070,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nFWN44225J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7511","BK7508","BK7501","CSL.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}